BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37164172)

  • 1. The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years' experience of association studies to understand the genetic architecture of pancreatic cancer.
    Campa D; Gentiluomo M; Stein A; Aoki MN; Oliverius M; Vodičková L; Jamroziak K; Theodoropoulos G; Pasquali C; Greenhalf W; Arcidiacono PG; Uzunoglu F; Pezzilli R; Luchini C; Puzzono M; Loos M; Giaccherini M; Katzke V; Mambrini A; Kiudeliene E; Federico KE; Johansen J; Hussein T; Mohelnikova-Duchonova B; van Eijck CHJ; Brenner H; Farinella R; Pérez JS; Lovecek M; Büchler MW; Hlavac V; Izbicki JR; Hackert T; Chammas R; Zerbi A; Lawlor R; Felici A; Götz M; Capurso G; Ginocchi L; Gazouli M; Kupcinskas J; Cavestro GM; Vodicka P; Moz S; Neoptolemos JP; Kunovsky L; Bojesen SE; Carrara S; Gioffreda D; Morkunas E; Abian O; Bunduc S; Basso D; Boggi U; Wlodarczyk B; Szentesi A; Vanella G; Chen I; Bijlsma MF; Kiudelis V; Landi S; Schöttker B; Corradi C; Giese N; Kaaks R; Peduzzi G; Hegyi P; Morelli L; Furbetta N; Soucek P; Latiano A; Talar-Wojnarowska R; Lindgaard SC; Dijk F; Milanetto AC; Tavano F; Cervena K; Erőss B; Testoni SG; Verhagen-Oldenampsen JHE; Małecka-Wojciesko E; Costello E; Salvia R; Maiello E; Ermini S; Sperti C; Holleczek B; Perri F; Skieceviciene J; Archibugi L; Lucchesi M; Rizzato C; Canzian F
    Crit Rev Oncol Hematol; 2023 Jun; 186():104020. PubMed ID: 37164172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Susceptibility in Understanding of Pancreatic Ductal Adenocarcinoma Risk: A Decade-Long Effort of the PANDORA Consortium.
    Vodickova L; Horak J; Vodicka P
    Cancer Epidemiol Biomarkers Prev; 2022 May; 31(5):942-948. PubMed ID: 35506247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation.
    Campa D; Pastore M; Capurso G; Hackert T; Di Leo M; Izbicki JR; Khaw KT; Gioffreda D; Kupcinskas J; Pasquali C; Macinga P; Kaaks R; Stigliano S; Peeters PH; Key TJ; Talar-Wojnarowska R; Vodicka P; Valente R; Vashist YK; Salvia R; Papaconstantinou I; Shimizu Y; Valsuani C; Zambon CF; Gazouli M; Valantiene I; Niesen W; Mohelnikova-Duchonova B; Hara K; Soucek P; Malecka-Panas E; Bueno-de-Mesquita HBA; Johnson T; Brenner H; Tavano F; Fogar P; Ito H; Sperti C; Butterbach K; Latiano A; Andriulli A; Cavestro GM; Busch ORC; Dijk F; Greenhalf W; Matsuo K; Lombardo C; Strobel O; König AK; Cuk K; Strothmann H; Katzke V; Cantore M; Mambrini A; Oliverius M; Pezzilli R; Landi S; Canzian F
    Int J Cancer; 2018 Jan; 142(2):290-296. PubMed ID: 28913878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium.
    Rizzato C; Campa D; Pezzilli R; Soucek P; Greenhalf W; Capurso G; Talar-Wojnarowska R; Heller A; Jamroziak K; Khaw KT; Key TJ; Bambi F; Landi S; Mohelnikova-Duchonova B; Vodickova L; Büchler MW; Bugert P; Vodicka P; Neoptolemos JP; Werner J; Hoheisel JD; Bauer AS; Giese N; Canzian F
    Oncol Rep; 2013 Apr; 29(4):1637-44. PubMed ID: 23403949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of replication of seven pancreatic cancer susceptibility loci identified in two Asian populations.
    Campa D; Rizzato C; Bauer AS; Werner J; Capurso G; Costello E; Talar-Wojnarowska R; Jamroziak K; Pezzilli R; Gazouli M; Khaw KT; Key TJ; Bambi F; Mohelnikova-Duchonova B; Heller A; Landi S; Vodickova L; Theodoropoulos G; Bugert P; Vodicka P; Hoheisel JD; Delle Fave G; Neoptolemos JP; Soucek P; Büchler MW; Giese N; Canzian F
    Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):320-3. PubMed ID: 23250936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium.
    Campa D; Rizzato C; Capurso G; Giese N; Funel N; Greenhalf W; Soucek P; Gazouli M; Pezzilli R; Pasquali C; Talar-Wojnarowska R; Cantore M; Andriulli A; Scarpa A; Jamroziak K; Delle Fave G; Costello E; Khaw KT; Heller A; Key TJ; Theodoropoulos G; Malecka-Panas E; Mambrini A; Bambi F; Landi S; Pedrazzoli S; Bassi C; Pacetti P; Piepoli A; Tavano F; di Sebastiano P; Vodickova L; Basso D; Plebani M; Fogar P; Büchler MW; Bugert P; Vodicka P; Boggi U; Neoptolemos JP; Werner J; Canzian F
    Dig Liver Dis; 2013 Feb; 45(2):95-9. PubMed ID: 23206934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms.
    Obazee O; Capurso G; Tavano F; Archibugi L; De Bonis A; Greenhalf W; Key T; Pasquali C; Milanetto AC; Hackert T; Fogar P; Liço V; Dervenis C; Lawlor RT; Landoni L; Gazouli M; Zambon CF; Funel N; Strobel O; Jamroziak K; Cantù C; Malecka-Panas E; Landi S; Neoptolemos JP; Basso D; Talar-Wojnarowska R; Rinzivillo M; Andriulli A; Canzian F; Campa D
    Carcinogenesis; 2018 Mar; 39(3):360-367. PubMed ID: 29309705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.
    Klein AP; Wolpin BM; Risch HA; Stolzenberg-Solomon RZ; Mocci E; Zhang M; Canzian F; Childs EJ; Hoskins JW; Jermusyk A; Zhong J; Chen F; Albanes D; Andreotti G; Arslan AA; Babic A; Bamlet WR; Beane-Freeman L; Berndt SI; Blackford A; Borges M; Borgida A; Bracci PM; Brais L; Brennan P; Brenner H; Bueno-de-Mesquita B; Buring J; Campa D; Capurso G; Cavestro GM; Chaffee KG; Chung CC; Cleary S; Cotterchio M; Dijk F; Duell EJ; Foretova L; Fuchs C; Funel N; Gallinger S; M Gaziano JM; Gazouli M; Giles GG; Giovannucci E; Goggins M; Goodman GE; Goodman PJ; Hackert T; Haiman C; Hartge P; Hasan M; Hegyi P; Helzlsouer KJ; Herman J; Holcatova I; Holly EA; Hoover R; Hung RJ; Jacobs EJ; Jamroziak K; Janout V; Kaaks R; Khaw KT; Klein EA; Kogevinas M; Kooperberg C; Kulke MH; Kupcinskas J; Kurtz RJ; Laheru D; Landi S; Lawlor RT; Lee IM; LeMarchand L; Lu L; Malats N; Mambrini A; Mannisto S; Milne RL; Mohelníková-Duchoňová B; Neale RE; Neoptolemos JP; Oberg AL; Olson SH; Orlow I; Pasquali C; Patel AV; Peters U; Pezzilli R; Porta M; Real FX; Rothman N; Scelo G; Sesso HD; Severi G; Shu XO; Silverman D; Smith JP; Soucek P; Sund M; Talar-Wojnarowska R; Tavano F; Thornquist MD; Tobias GS; Van Den Eeden SK; Vashist Y; Visvanathan K; Vodicka P; Wactawski-Wende J; Wang Z; Wentzensen N; White E; Yu H; Yu K; Zeleniuch-Jacquotte A; Zheng W; Kraft P; Li D; Chanock S; Obazee O; Petersen GM; Amundadottir LT
    Nat Commun; 2018 Feb; 9(1):556. PubMed ID: 29422604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA study.
    Campa D; Matarazzi M; Greenhalf W; Bijlsma M; Saum KU; Pasquali C; van Laarhoven H; Szentesi A; Federici F; Vodicka P; Funel N; Pezzilli R; Bueno-de-Mesquita HB; Vodickova L; Basso D; Obazee O; Hackert T; Soucek P; Cuk K; Kaiser J; Sperti C; Lovecek M; Capurso G; Mohelnikova-Duchonova B; Khaw KT; König AK; Kupcinskas J; Kaaks R; Bambi F; Archibugi L; Mambrini A; Cavestro GM; Landi S; Hegyi P; Izbicki JR; Gioffreda D; Zambon CF; Tavano F; Talar-Wojnarowska R; Jamroziak K; Key TJ; Fave GD; Strobel O; Jonaitis L; Andriulli A; Lawlor RT; Pirozzi F; Katzke V; Valsuani C; Vashist YK; Brenner H; Canzian F
    Int J Cancer; 2019 Mar; 144(6):1275-1283. PubMed ID: 30325019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma.
    Obazee O; Archibugi L; Andriulli A; Soucek P; Małecka-Panas E; Ivanauskas A; Johnson T; Gazouli M; Pausch T; Lawlor RT; Cavestro GM; Milanetto AC; Di Leo M; Pasquali C; Hegyi P; Szentesi A; Radu CE; Gheorghe C; Theodoropoulos GE; Bergmann F; Brenner H; Vodickova L; Katzke V; Campa D; Strobel O; Kaiser J; Pezzilli R; Federici F; Mohelnikova-Duchonova B; Boggi U; Lemstrova R; Johansen JS; Bojesen SE; Chen I; Jensen BV; Capurso G; Pazienza V; Dervenis C; Sperti C; Mambrini A; Hackert T; Kaaks R; Basso D; Talar-Wojnarowska R; Maiello E; Izbicki JR; Cuk K; Saum KU; Cantore M; Kupcinskas J; Palmieri O; Delle Fave G; Landi S; Salvia R; Fogar P; Vashist YK; Scarpa A; Vodicka P; Tjaden C; Iskierka-Jazdzewska E; Canzian F
    Int J Cancer; 2019 Aug; 145(3):686-693. PubMed ID: 30672594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide association study identifies an early onset pancreatic cancer risk locus.
    Campa D; Gentiluomo M; Obazee O; Ballerini A; Vodickova L; Hegyi P; Soucek P; Brenner H; Milanetto AC; Landi S; Gao X; Bozzato D; Capurso G; Tavano F; Vashist Y; Hackert T; Bambi F; Bursi S; Oliverius M; Gioffreda D; Schöttker B; Ivanauskas A; Mohelnikova-Duchonova B; Darvasi E; Pezzilli R; Małecka-Panas E; Strobel O; Gazouli M; Katzke V; Szentesi A; Cavestro GM; Farkas G; Izbicki JR; Moz S; Archibugi L; Hlavac V; Vincze Á; Talar-Wojnarowska R; Rusev B; Kupcinskas J; Greenhalf B; Dijk F; Giese N; Boggi U; Andriulli A; Busch OR; Vanella G; Vodicka P; Nentwich M; Lawlor RT; Theodoropoulos GE; Jamroziak K; Zuppardo RA; Moletta L; Ginocchi L; Kaaks R; Neoptolemos JP; Lucchesi M; Canzian F
    Int J Cancer; 2020 Oct; 147(8):2065-2074. PubMed ID: 32270874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk.
    Campa D; Pastore M; Gentiluomo M; Talar-Wojnarowska R; Kupcinskas J; Malecka-Panas E; Neoptolemos JP; Niesen W; Vodicka P; Delle Fave G; Bueno-de-Mesquita HB; Gazouli M; Pacetti P; Di Leo M; Ito H; Klüter H; Soucek P; Corbo V; Yamao K; Hosono S; Kaaks R; Vashist Y; Gioffreda D; Strobel O; Shimizu Y; Dijk F; Andriulli A; Ivanauskas A; Bugert P; Tavano F; Vodickova L; Zambon CF; Lovecek M; Landi S; Key TJ; Boggi U; Pezzilli R; Jamroziak K; Mohelnikova-Duchonova B; Mambrini A; Bambi F; Busch O; Pazienza V; Valente R; Theodoropoulos GE; Hackert T; Capurso G; Cavestro GM; Pasquali C; Basso D; Sperti C; Matsuo K; Büchler M; Khaw KT; Izbicki J; Costello E; Katzke V; Michalski C; Stepien A; Rizzato C; Canzian F
    Oncotarget; 2016 Aug; 7(35):57011-57020. PubMed ID: 27486979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Small Proteins and Peptides in the Differentiation of Patients with Intraductal Mucinous Neoplasms of the Pancreas, Chronic Pancreatitis and Pancreatic Adenocarcinoma.
    Fania C; Pezzilli R; Melzi d'Eril G; Gelfi C; Barassi A
    Dig Dis Sci; 2018 Apr; 63(4):920-933. PubMed ID: 29417328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction.
    Galeotti AA; Gentiluomo M; Rizzato C; Obazee O; Neoptolemos JP; Pasquali C; Nentwich M; Cavestro GM; Pezzilli R; Greenhalf W; Holleczek B; Schroeder C; Schöttker B; Ivanauskas A; Ginocchi L; Key TJ; Hegyi P; Archibugi L; Darvasi E; Basso D; Sperti C; Bijlsma MF; Palmieri O; Hlavac V; Talar-Wojnarowska R; Mohelnikova-Duchonova B; Hackert T; Vashist Y; Strouhal O; van Laarhoven H; Tavano F; Lovecek M; Dervenis C; Izbéki F; Padoan A; Małecka-Panas E; Maiello E; Vanella G; Capurso G; Izbicki JR; Theodoropoulos GE; Jamroziak K; Katzke V; Kaaks R; Mambrini A; Papanikolaou IS; Szmola R; Szentesi A; Kupcinskas J; Bursi S; Costello E; Boggi U; Milanetto AC; Landi S; Gazouli M; Vodickova L; Soucek P; Gioffreda D; Gemignani F; Brenner H; Strobel O; Büchler M; Vodicka P; Paiella S; Canzian F; Campa D
    J Med Genet; 2021 Jun; 58(6):369-377. PubMed ID: 32591343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance of patients with intraductal papillary mucinous neoplasm with and without pancreatectomy with special reference to the incidence of concomitant pancreatic ductal adenocarcinoma.
    Date K; Ohtsuka T; Nakamura S; Mochidome N; Mori Y; Miyasaka Y; Oda Y; Nakamura M
    Surgery; 2018 Feb; 163(2):291-299. PubMed ID: 29221879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial intraductal papillary mucinous neoplasms of the pancreas.
    Rebours V; Couvelard A; Peyroux JL; Sauvanet A; Hammel P; Ruszniewski P; Lévy P
    Dig Liver Dis; 2012 May; 44(5):442-6. PubMed ID: 21824831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival comparison of invasive intraductal papillary mucinous neoplasm versus pancreatic ductal adenocarcinoma.
    Takeda Y; Imamura H; Yoshimoto J; Fukumura Y; Yoshioka R; Mise Y; Kawasaki S; Saiura A
    Surgery; 2022 Jul; 172(1):336-342. PubMed ID: 35197219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic papillary pattern in pancreatic ductal adenocarcinoma: a heretofore undescribed morphologic pattern that mimics intraductal papillary mucinous carcinoma.
    Kelly PJ; Shinagare S; Sainani N; Hong X; Ferrone C; Yilmaz O; Fernández-del Castillo C; Lauwers GY; Deshpande V
    Am J Surg Pathol; 2012 May; 36(5):696-701. PubMed ID: 22367300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas.
    Hong SM; Kelly D; Griffith M; Omura N; Li A; Li CP; Hruban RH; Goggins M
    Mod Pathol; 2008 Dec; 21(12):1499-507. PubMed ID: 18820670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UEG position paper on pancreatic cancer. Bringing pancreatic cancer to the 21st century: Prevent, detect, and treat the disease earlier and better.
    Michl P; Löhr M; Neoptolemos JP; Capurso G; Rebours V; Malats N; Ollivier M; Ricciardiello L
    United European Gastroenterol J; 2021 Sep; 9(7):860-871. PubMed ID: 34431604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.